MetaVia Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from MetaVia Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 98% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 93% of Healthcare companies in United States.
- Cash Cushion Ratio: Cash, after subtracting all debt, is 1.1 times its market value (net cash). Higher than 90% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-853.5×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 98% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-230.9×Operating cash was negative last year, while some debt falls due within a year.
Lower than 93% of Healthcare companies in United States.
Cash Cushion Ratio
1.1× cashCash, after subtracting all debt, is 1.1 times its market value (net cash).
Higher than 90% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
MetaVia Inc. made a loss over the last year. MetaVia Inc. owes $0.49 for every $1 it owns. MetaVia Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossMetaVia Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.34The share price is 1.34 times MetaVia Inc.'s book value per share, lower than 72% of Healthcare companies in United States.
Market cap
$9 MThe total market value of all of MetaVia Inc.'s shares at today's price (share price × number of shares), smaller than 88% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$7 MWhat MetaVia Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.04Net worth divided by the number of shares. The share price of $1.39 is 1.3 times this, which is the P/B above.
Return on equity (ROE)
-175.7%MetaVia Inc. lost 175.7% of its shareholders' money over the last year, lower than 82% of Healthcare companies in United States.
Owes vs Owns
0.49×MetaVia Inc. owes $0.49 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.
Dividend yield
NoneMetaVia Inc. does not currently pay a dividend.
Profit growth
LossMetaVia Inc. made a loss in each of the last two years.
Cash vs debt
Net cashMetaVia Inc. held $10 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For MetaVia Inc.: $9 M ÷ $7 M (30 Jun 2026) = 1.3.
What is MetaVia Inc.'s return on equity?
MetaVia Inc. lost 175.7% of its shareholders' money over the last year, lower than 82% of Healthcare companies in United States.
How much does MetaVia Inc. owe compared with what it owns?
MetaVia Inc. owes $0.49 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.
Does MetaVia Inc. pay a dividend?
No. MetaVia Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.